Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer

Clinical trial NCT06650423 · RECRUITING

Trial details

NCT number: NCT06650423
Sponsor: Institute of Oncology Ljubljana
Status: RECRUITING
Study type: OBSERVATIONAL

Early Breast Cancer Hormone Receptor Positive Tumor HER2-negative Breast Cancer

Start date: 2025-01-05
Primary completion: 2027-03-01
Enrollment: 319

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.